These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23933588)

  • 1. Pkd1 is required for male reproductive tract development.
    Nie X; Arend LJ
    Mech Dev; 2013; 130(11-12):567-76. PubMed ID: 23933588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel roles of Pkd2 in male reproductive system development.
    Nie X; Arend LJ
    Differentiation; 2014; 87(3-4):161-71. PubMed ID: 24951251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pkd1-targeted mutation reveals a role for the Wolffian duct in autosomal dominant polycystic kidney disease.
    Tee JB; Dnyanmote AV; Lorenzo MK; Lee OR; Grisaru S; Suk M; Acott PD
    J Dev Orig Health Dis; 2020 Feb; 11(1):78-85. PubMed ID: 31412963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin-mediated suppression of renal cyst expansion in del34 Pkd1-/- mutant mouse embryos: an investigation of the feasibility of renal cyst prevention in the foetus.
    Stayner C; Shields J; Slobbe L; Shillingford JM; Weimbs T; Eccles MR
    Nephrology (Carlton); 2012 Nov; 17(8):739-47. PubMed ID: 22725947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pax2 gene dosage influences cystogenesis in autosomal dominant polycystic kidney disease.
    Stayner C; Iglesias DM; Goodyer PR; Ellis L; Germino G; Zhou J; Eccles MR
    Hum Mol Genet; 2006 Dec; 15(24):3520-8. PubMed ID: 17082250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystin-1 dysfunction impairs electrolyte and water handling in a renal precystic mouse model for ADPKD.
    Verschuren EHJ; Mohammed SG; Leonhard WN; Overmars-Bos C; Veraar K; Hoenderop JGJ; Bindels RJM; Peters DJM; Arjona FJ
    Am J Physiol Renal Physiol; 2018 Sep; 315(3):F537-F546. PubMed ID: 29767557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA helicase p68 inhibits the transcription and post-transcription of
    Zhang L; Li LX; Zhou JX; Harris PC; Calvet JP; Li X
    Theranostics; 2020; 10(18):8281-8297. PubMed ID: 32724471
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel mutations of PKD genes in Chinese patients suffering from autosomal dominant polycystic kidney disease and seeking assisted reproduction.
    He WB; Xiao WJ; Tan YQ; Zhao XM; Li W; Zhang QJ; Zhong CG; Li XR; Hu L; Lu GX; Lin G; Du J
    BMC Med Genet; 2018 Oct; 19(1):186. PubMed ID: 30333007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Pkd1-Fbn1 genetic interaction implicates TGF-β signaling in the pathogenesis of vascular complications in autosomal dominant polycystic kidney disease.
    Liu D; Wang CJ; Judge DP; Halushka MK; Ni J; Habashi JP; Moslehi J; Bedja D; Gabrielson KL; Xu H; Qian F; Huso D; Dietz HC; Germino GG; Watnick T
    J Am Soc Nephrol; 2014 Jan; 25(1):81-91. PubMed ID: 24071006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of Pkd1 in renal stromal cells causes defects in the renal stromal compartment and progressive cystogenesis in the kidney.
    Nie X; Arend LJ
    Lab Invest; 2017 Dec; 97(12):1427-1438. PubMed ID: 28892094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Myc is a regulator of the PKD1 gene and PC1-induced pathogenesis.
    Parrot C; Kurbegovic A; Yao G; Couillard M; Côté O; Trudel M
    Hum Mol Genet; 2019 Mar; 28(5):751-763. PubMed ID: 30388220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferroptosis Promotes Cyst Growth in Autosomal Dominant Polycystic Kidney Disease Mouse Models.
    Zhang X; Li LX; Ding H; Torres VE; Yu C; Li X
    J Am Soc Nephrol; 2021 Nov; 32(11):2759-2776. PubMed ID: 34716241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model.
    Leonhard WN; van der Wal A; Novalic Z; Kunnen SJ; Gansevoort RT; Breuning MH; de Heer E; Peters DJ
    Am J Physiol Renal Physiol; 2011 May; 300(5):F1193-202. PubMed ID: 21345977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Mechanisms of ADPKD.
    Kim DY; Park JH
    Adv Exp Med Biol; 2016; 933():13-22. PubMed ID: 27730431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autosomal dominant polycystic kidney disease: clues to pathogenesis.
    Harris PC
    Hum Mol Genet; 1999; 8(10):1861-6. PubMed ID: 10469838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease.
    Seeger-Nukpezah T; Proia DA; Egleston BL; Nikonova AS; Kent T; Cai KQ; Hensley HH; Ying W; Chimmanamada D; Serebriiskii IG; Golemis EA
    Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12786-91. PubMed ID: 23858461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current advances in molecular genetics of autosomal-dominant polycystic kidney disease.
    Wu G
    Curr Opin Nephrol Hypertens; 2001 Jan; 10(1):23-31. PubMed ID: 11195048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triptolide reduces cyst formation in a neonatal to adult transition Pkd1 model of ADPKD.
    Leuenroth SJ; Bencivenga N; Chahboune H; Hyder F; Crews CM
    Nephrol Dial Transplant; 2010 Jul; 25(7):2187-94. PubMed ID: 20139063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity.
    Hopp K; Ward CJ; Hommerding CJ; Nasr SH; Tuan HF; Gainullin VG; Rossetti S; Torres VE; Harris PC
    J Clin Invest; 2012 Nov; 122(11):4257-73. PubMed ID: 23064367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mcp1 Promotes Macrophage-Dependent Cyst Expansion in Autosomal Dominant Polycystic Kidney Disease.
    Cassini MF; Kakade VR; Kurtz E; Sulkowski P; Glazer P; Torres R; Somlo S; Cantley LG
    J Am Soc Nephrol; 2018 Oct; 29(10):2471-2481. PubMed ID: 30209078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.